粗略
发表于 2025-3-21 19:27:32
书目名称Cannabis and Cannabinoid-Based Medicines in Cancer Care影响因子(影响力)<br> http://impactfactor.cn/if/?ISSN=BK0221320<br><br> <br><br>书目名称Cannabis and Cannabinoid-Based Medicines in Cancer Care影响因子(影响力)学科排名<br> http://impactfactor.cn/ifr/?ISSN=BK0221320<br><br> <br><br>书目名称Cannabis and Cannabinoid-Based Medicines in Cancer Care网络公开度<br> http://impactfactor.cn/at/?ISSN=BK0221320<br><br> <br><br>书目名称Cannabis and Cannabinoid-Based Medicines in Cancer Care网络公开度学科排名<br> http://impactfactor.cn/atr/?ISSN=BK0221320<br><br> <br><br>书目名称Cannabis and Cannabinoid-Based Medicines in Cancer Care被引频次<br> http://impactfactor.cn/tc/?ISSN=BK0221320<br><br> <br><br>书目名称Cannabis and Cannabinoid-Based Medicines in Cancer Care被引频次学科排名<br> http://impactfactor.cn/tcr/?ISSN=BK0221320<br><br> <br><br>书目名称Cannabis and Cannabinoid-Based Medicines in Cancer Care年度引用<br> http://impactfactor.cn/ii/?ISSN=BK0221320<br><br> <br><br>书目名称Cannabis and Cannabinoid-Based Medicines in Cancer Care年度引用学科排名<br> http://impactfactor.cn/iir/?ISSN=BK0221320<br><br> <br><br>书目名称Cannabis and Cannabinoid-Based Medicines in Cancer Care读者反馈<br> http://impactfactor.cn/5y/?ISSN=BK0221320<br><br> <br><br>书目名称Cannabis and Cannabinoid-Based Medicines in Cancer Care读者反馈学科排名<br> http://impactfactor.cn/5yr/?ISSN=BK0221320<br><br> <br><br>
infinite
发表于 2025-3-21 23:25:15
Book 2022 issues of drug-drug interactions and other challenges involved in prescribing CBM to frail patientswith polypharmacy and multiple comorbidities. Comparing available products, both approved and non-approved by the FDA, the book discusses regional challenges for accessing reliably tested and labelled
Homocystinuria
发表于 2025-3-22 01:12:01
http://reply.papertrans.cn/23/2214/221320/221320_3.png
高度表
发表于 2025-3-22 05:32:29
http://reply.papertrans.cn/23/2214/221320/221320_4.png
刀锋
发表于 2025-3-22 11:38:55
http://reply.papertrans.cn/23/2214/221320/221320_5.png
逃避现实
发表于 2025-3-22 16:35:01
New Thinking about World Communism,ctions are largely inhibitory in nature and encountered through the CYP2C family. Other drug interactions via immunomodulatory mechanisms have been shown to reduce efficacy of check-point inhibitors and are a reminder that cannabis use should be closely monitored in cancer patients.
逃避现实
发表于 2025-3-22 19:06:57
http://reply.papertrans.cn/23/2214/221320/221320_7.png
清楚说话
发表于 2025-3-23 01:06:12
http://reply.papertrans.cn/23/2214/221320/221320_8.png
滔滔不绝地讲
发表于 2025-3-23 05:23:43
http://reply.papertrans.cn/23/2214/221320/221320_9.png
刺穿
发表于 2025-3-23 05:58:18
Group therapy with the very olds, suppositories, etc. Most patients will benefit from oral or oromucosal administration for baseline administration, while inhaled cannabis is reserved for breakthrough or episodic symptoms in specific clinical settings..The main active ingredients of cannabis are THC and CBD, which have their own